DIN 02456893 — MYLAN-ATAZANAVIR 300 MG
MYLAN-ATAZANAVIR is a capsule of Atazanavir marketed by MYLAN PHARMACEUTICALS ULC. The full Atazanavir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02456893
- Brand name
- MYLAN-ATAZANAVIR
- Active ingredient
- Atazanavir
- Strength
- 300 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- MYLAN PHARMACEUTICALS ULC
- Health Canada status
- MARKETED
- Drug class
- Azapeptide HIV-1 protease inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Atazanavir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02513102 | JAMP ATAZANAVIR | 150 MG | CAPSULE | JAMP PHARMA CORPORATION | DORMANT |
| 02513110 | JAMP ATAZANAVIR | 200 MG | CAPSULE | JAMP PHARMA CORPORATION | DORMANT |
| 02513129 | JAMP ATAZANAVIR | 300 MG | CAPSULE | JAMP PHARMA CORPORATION | DORMANT |
| 02456877 | MYLAN-ATAZANAVIR | 150 MG | CAPSULE | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02456885 | MYLAN-ATAZANAVIR | 200 MG | CAPSULE | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02443791 | TEVA-ATAZANAVIR | 150 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |
| 02443813 | TEVA-ATAZANAVIR | 200 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |
| 02443821 | TEVA-ATAZANAVIR | 300 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |